ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Super CAR-T cells take on advanced liver cancer in first human trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called Super CAR-T for people with advanced liver cancer that has not responded to standard therapies. The therapy uses a patient's own immune cells, modified to target a protein called GPC3 found on cancer cells. The main goals are to…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1 • Sponsor: Guangzhou FineImmune Biotechnology Co., LTD. • Aim: Disease control
Last updated May 17, 2026 05:45 UTC
-
New super immune cells take on advanced liver cancer
Disease control Recruiting nowThis study tests a new treatment called super Hi-TCR-T cells for people with advanced liver cancer that has not responded to other therapies. The cells are designed to attack multiple targets on cancer cells. About 30 participants will receive the treatment to see if it is safe a…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1, PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Engineered immune cells take on advanced liver cancer in early trial
Disease control Recruiting nowThis early study tests a new treatment for advanced liver cancer that has not responded to standard therapies. It uses the patient's own immune cells, modified in a lab to target a protein called GPC3 found on cancer cells. The main goals are to check safety and find the right do…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: NA • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Engineered immune cells take on Hard-to-Treat liver cancer
Disease control Recruiting nowThis study tests a new treatment for adults with advanced liver cancer that has not responded to standard therapies. The treatment uses specially designed immune cells from a donor to target two proteins on cancer cells. The goal is to see if the treatment is safe and can shrink …
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New combo therapy shows promise for advanced liver cancer
Disease control Recruiting nowThis study tests a new treatment for advanced liver cancer that has spread. It combines a drug called adebrelimab (given either into the liver artery or a vein) with standard chemotherapy and another drug. The goal is to see if this approach shrinks tumors better than current opt…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New hope for liver cancer patients: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug, WGI-0301, combined with sorafenib in 60 adults with advanced liver cancer that cannot be removed by surgery and has not responded to prior immunotherapy. The goal is to find the safest dose and see if the combination can shrink tumors. Participants mu…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Zhejiang Haichang Biotech Co., Ltd. • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
New combo therapy targets hard-to-treat liver cancer with vascular invasion
Disease control Recruiting nowThis study is for people with advanced liver cancer that has grown into major blood vessels. It tests whether adding a type of radiation (particle beam) to standard immunotherapy can help control the cancer longer. About 128 adults will take part. The goal is to see if the combin…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
New study tracks immune changes in liver cancer patients on immunotherapy
Knowledge-focused Recruiting nowThis study is for people with advanced liver cancer who have not had prior treatment. It observes how different first-line immunotherapies affect tumors and the immune system. The goal is to learn which treatments work best and why, without providing direct treatment. About 150 a…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated May 06, 2026 16:13 UTC